Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

BioNexus Gene Lab (BGLC) Leases (2019 - 2025)

BioNexus Gene Lab's Leases history spans 7 years, with the latest figure at $177737.0 for Q4 2025.

  • Quarterly results put Leases at $177737.0 for Q4 2025, down 17.42% from a year ago — trailing twelve months through Dec 2025 was $177737.0 (down 17.42% YoY), and the annual figure for FY2025 was $177737.0, down 17.42%.
  • Leases for Q4 2025 was $177737.0 at BioNexus Gene Lab, down from $186082.0 in the prior quarter.
  • In the past five years, Leases ranged from a high of $241700.0 in Q2 2024 to a low of $24975.0 in Q3 2022.
  • The 5-year median for Leases is $91961.5 (2021), against an average of $115280.0.
  • The sharpest move saw Leases crashed 44.02% in 2022, then surged 466.74% in 2023.
  • Year by year, Leases stood at $41090.0 in 2021, then skyrocketed by 35.63% to $55730.0 in 2022, then surged by 153.98% to $141544.0 in 2023, then soared by 52.07% to $215243.0 in 2024, then decreased by 17.42% to $177737.0 in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $177737.0, $186082.0, and $200284.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.